Does anyone know where these special use cases are from ? I assume Australia or maybe NZ as the yanks would be too scared to use anything the FDA hadn't OK'ed as they might get sued out of existence.
Hopefully the word is spreading within the profession & more special use cases will happen, with the same amazing results.
An article on these special use cases in some prestigious medical journal would be handyIt seems to me that would be justified as IMO it is big news.
.
Ann: Additional Positive Patient Cases - Special Access Scheme, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.5¢ | 46.0¢ | $145.6K | 316.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 82151 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 57606 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |